| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fb2d98b6a39f6ff56edaa8084254cfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c87b3d7ac100dbdc7843d82cb5ae2491 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191 |
| filingDate |
2016-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a8aa6a362e3e5507dbf72cec5d5719 |
| publicationDate |
2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9801840-B1 |
| titleOfInvention |
Pharmaceutical composition and use thereof |
| abstract |
The present invention provides a pharmaceutical composition including a therapeutically efficient amount of a compound represented by formula (1), at least an anticancer agent, and a pharmaceutically acceptable carrier. The present invention further provides a use of the compound represented by formula (1) for the manufacture of a medicament for treating hepatocellular carcinoma. |
| priorityDate |
2016-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |